Table 2.
Comparison of clinical data of three groups of subjects
| Clinical data | Control group (n=50) | T2D group (n=83) | DN group (n=65) | Statistics | P |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 21 | 38 | 28 | 0.209 | 0.901 |
| Female | 29 | 45 | 37 | ||
| Age (y, x̅±s) | 58.39±7.29 | 59.17±8.33 | 58.26±7.05 | 0.302 | 0.739 |
| Triglyceride (mmol/L, x̅±s) | 1.52±0.50* | 1.98±0.61* | 3.09±0.89 | 81.861 | <0.001 |
| FBG (mmol/L, x̅±s) | 5.68±0.79* | 8.30±1.56* | 9.17±1.64 | 88.327 | <0.001 |
| Course of diabetes (y, x̅±s) | - | 14.27±5.20 | 15.13±6.12 | 0.933 | 0.357 |
| BMI (kg/m2, x̅±s) | 24.89±4.17 | 25.28±4.12 | 26.03±5.10 | 0.994 | 0.372 |
| Proteinuria (mg/24 h, x̅±s) | 2.19±0.79* | 7.80±2.67* | 1560.28±129.32 | 9606.800 | <0.001 |
| Serum creatinine (mmol/L, x̅±s) | 58.92±12.01* | 61.29±12.18* | 148.39±37.48 | 302.159 | <0.001 |
| Glycosylated hemoglobin (%, x̅±s) | 3.08±0.79* | 8.89±1.73* | 9.93±1.84 | 298.268 | <0.001 |
Note: In the table, the three groups of counted data were compared by rank sum test, the three groups of measured data were compared by analysis of variance, and the two groups of measured data were compared by t test. Compared to the DN group, using post-hoc analysis;
*
P<0.05.